| Literature DB >> 35450143 |
Victor Andrés Ayala-Rodríguez1, Abad Arturo López-Hernández1, Manuel López-Cabanillas Lomelí1, Blanca Edelia González-Martínez1, Jesús Alberto Vázquez-Rodríguez1.
Abstract
Fava bean (Vicia faba L.) is a high-protein crop consumed worldwide and is an exceptional plant-based protein source for human consumption. The present study evaluated in vitro nutritional properties of four different protein flours of fava bean: minimal processed flour (MPF), cooked flour (CF), non-polyphenol protein concentrate (NPP), and polyphenol-protein concentrate (PP). NPP showed the highest protein concentration of 94.39 ± 0.76%. The heat treatment significantly increased the in vitro protein digestibility in CF (94.15 ± 2.45%). NPP and PP showed the highest bioaccessibility, 29.85 ± 1.88 and 33.19 ± 1.65%, respectively, no significant differences. SDS-PAGE analysis revealed bioaccessible low molecular weight peptides (<15 kDa) and legumin and vicilin presence. In silico analysis of bioactive peptides of legumin and vicilin presented high occurrence frequencies of bioactivities, as angiotensin-converting enzyme-inhibitor and dipeptidyl peptidase III/IV inhibitor peptides. This study supports the use and further investigation of fava bean proteins for human nutrition.Entities:
Keywords: Bioactive peptides; Fava bean; Fava bean flour; Food proteins; In vitro protein bioaccesibility; In vitro protein digestibility; Vicia faba
Year: 2022 PMID: 35450143 PMCID: PMC9018142 DOI: 10.1016/j.fochx.2022.100303
Source DB: PubMed Journal: Food Chem X ISSN: 2590-1575
Proximal composition of minimal processed flour, cooked flour, non-polyphenol protein flour and protein flour with polyphenols of fava bean (Vicia faba L).
| MPF | 3.34 ± 0.70a | 3.17 ± 0.40a | 26.47 ± 0.26a | 2.00 ± 0.20c | 1.89 ± 0.02a | 63.13 ± 1.07a |
| CF | 5.79 ± 0.98bc | 3.26 ± 0.02a | 27.98 ± 0.25b | 1.66 ± 0.29bc | 1.78 ± 0.12a | 57.86 ± 3.16b |
| NPP | 4.08 ± 0.15ab | 2.66 ± 0.08a | 94.39 ± 0.76c | 0.41 ± 0.06a | <0.1b | <0.1c |
| PP | 7.55 ± 0.85c | 2.90 ± 0.43a | 84.37 ± 0.30d | 1.43 ± 0.15b | <0.1b | 3.29 ± 0.50d |
MPF = minimal processed flour, CF = cooked flour, NPP = non-polyphenol protein flour, PP = polyphenol protein flour.
Data expressed in % (w/w) dry basis, mean ± SD (n = 3).
Means with different superscripts in columns differ significantly (p < 0.05).
Comparison of the amino acid profile and nutritional parameters of minimal processed flour, cooked flour, non-polyphenol protein flour and polyphenol protein flour.
| Ala | 3.25 | 3.54 | 3.19 | 3.26 | – |
| Arg | 2.82 | 2.96 | 2.21 | 2.72 | – |
| Asp | 5.78 | 6.17 | 6.70 | 6.20 | – |
| Phe + Tyr | 8.60 | 10.46 | 8.68 | 8.61 | 4.1 |
| Gly | 5.38 | 5.57 | 6.11 | 6.07 | – |
| Glu | 11.53 | 14.06 | 14.96 | 13.02 | – |
| His | 18.44 | 15.81 | 13.95 | 11.90 | 1.6 |
| Ile | 2.67 | 3.19 | 2.96 | 2.99 | 3.0 |
| Leu | 5.36 | 6.32 | 6.81 | 6.72 | 6.1 |
| Lys | 6.04 | 6.01 | 5.98 | 6.43 | 4.8 |
| Met + Cys | 1.41 | 1.81 | 1.02 | 1.21 | 2.3 |
| Ser | 2.80 | 2.77 | 3.19 | 3.27 | – |
| Thr | 15.29 | 9.16 | 16.60 | 15.87 | 2.5 |
| Trp | – | – | – | – | 0.66 |
| Val | 2.72 | 3.26 | 3.08 | 3.19 | 4.0 |
| Total protein (%) c | 26.47 | 27.98 | 94.39 | 84.37 | |
| Limiting essential amino acid | Met + Cys | Met + Cys | Met + Cys | Met + Cys | |
| AAS | 61 | 78 | 44 | 53 | 100 |
| 31.34 ± 1.40a | 94.15 ± 2.45d | 77.73 ± 2.26c | 71.09 ± 1.69b | ||
| 16.43 ± 0.40a | 20.47 ± 1.78b | 29.85 ± 1.88c | 33.19 ± 1.65c | ||
| 19.12 ± 0.86a | 73.44 ± 1.92d | 34.20 ± 0.99b | 37.68 ± 0.90c | ||
| E-PER | 1.43 | 1.75 | 2.15 | 2.11 |
MPF = minimal processed flour, CF = cooked flour, NPP = non-polyphenol protein flour, PP = polyphenol protein flour, IV-PD(%) = In vitro Protein Digestibility, IV-PB (%) = In vitro Protein Bioaccessibility, PDCAAS-IV = Amino Acid Score Corrected for In vitro Protein Digestibility. aComposition on a dry basis; bAmino acid requirement for children 3 to 10 years of age according to FAO, 2013; cDetermination of free amino acids with high pressure liquid chromatography performed; PDCAAS(%) = IVPD(%) × AAS, E-PER = Estimated protein efficiency ratio. Different superscript letters in the same row indicate significant statistical difference (ρ < 0.05).
Fig. 1Fava bean in vitro kinetics of Total protein released and Protein release rate *(mg/mL per minute) of MPF, CF, NPP and PP. MPF = minimal processed flour; CF = cooked flour NPP = non-polyphenol protein flour; PP = polyphenol protein flour.
Fig. 2Electrophoretic profile by molecular weight of NPP and PP of fava bean after in vitro digestion determined by SDS-PAGE. Lanes: M: Molecular weight marker; 1: NPP; 2: NPP gastric phase, 3: NPP intestinal phase, 4: NPP bioaccessible, 5: PP, 6: PP gastric phase, 7: PP intestinal phase, 8: PP bioaccessible and 9: digestive enzyme blank. NPP = non-polyphenol protein flour; PP = polyphenol protein flour.
Fig. 3Electrophoretic profile by molecular weight of fava bean MPF and fava bean CF after in vitro digestion determined by SDS-PAGE. Lanes: M: Molecular weight marker; 1: MPF; 2: MPF gastric phase, 3: MPF intestinal phase, 4: MPF bioaccessible, 5: CF, 6: CF gastric phase, 7: CF intestinal phase, 8 CF bioaccessible and 9: digestive enzyme blank. MPF = minimal processed flour; CF = cooked flour.
Predicted profiles of peptides (2–5 AA) in fava bean flours with biological activities. *.
| Legumin type B | ACE inhibitor | MSKP, TSTC, TET, CAGVS, IR, HL, IIQGK, GVIG, QEPR, QGSR, FR, YW, LVAIS, DSTPR, FY, HQQK, DGNSV, SG, AHT, LR, SPR, NQIVR, VEGG, SEQGR, NGL, YNPR, PIL, VR, NGI, YAPHW, VIR, GEGR, DNK, GQL, QVTE, SGNR | 0.2500–0.7500 |
| Antioxidative | MSKP, IR, HL, AHT, YAPHW, VIR, SGNR | 0.2500–0.6000 | |
| Dipeptidyl peptidase III/IV inhibitor | MSKP, FL, TSTC, ATSSE, NQCR, DNINA, TET, CAGVS, IR, HL, IIQGK, GVIG, TL, QEPR, SSQSR, QGSR, FR, YW, LVAIS, DSTPR, HQQK, DGNSV, AHT, LR | 0.2000–0.7500 | |
| Glucose uptake-stimulating peptide | ATSSE, IIQGK, LVAIS, SSE, NQIVR, SEQGR, PIL | 0.2000–0.3333 | |
| CaMPDE inhibitor | VIR, IR | 0.3333–0.5000 | |
| Renin inhibitor | IR, LR, VIR, SGNR | 0.3333–0.5000 | |
| Alpha-glucosidase inhibitor | VEGG, ADL | 0.2500–0.3333 | |
| Neuropeptide | YR, GQL s | 0.3333–0.5000 | |
| Vicilin | ACE inhibitor | MAATT, DSF, GIA, LQK, SGK, AIL, NSF, ER, GDTIK, SG, NIL, EAS, EIEK, EEHGK, EK, GLK, QIEE, NK, EPIY, SNK, GK, NPQL, PHY, GDF, VGQR, EEY, DEEK, PVAIK, VG, LAF, ENQK, ER, DHL, GS | 0.2000–0.6667 |
| Antioxidative | GLK, EPIY, PHY, DHL | 0.3333 | |
| Dipeptidyl peptidase III/IV inhibitor | MAATT, DSF, LL, GIA, ASVC, ESNR, QT, DQHSK, QN, VV, AIL, TV, LL, PNDR, NSF, GDTIK, VNR, SK, NIL, EAS, NTD, EIEK, LL, EEHGK, EK, HR, GLK, DR, QIEE, NAK, SSSK, FN, EPIY, NPQL, QD, VN, LL, PHY, VGQR, EEY, DEEK, QVQN, PVAIK, ASSN, VG, FL, LAF, ENQK, QSH, DHL, YSI | 0.2000–0.8000 | |
| Glucose uptake-stimulating peptide | LL, AIL, LL, DDEED, NIL, LL, EEHGK, QIEE, SSSK, LL, EEY, DEEK | 0.2000–0.5000 | |
| Renin inhibitor | DSF, ESNR, NSF, VNR | 0.2500–0.3333 | |
| Alpha-glucosidase inhibitor | EAS | 0.3333 | |
| Neuropeptide | VGQR | 0.2500 | |
| Anti-inflammatory | PHY | 0.3333 | |
| Antithrombotic | DDEED, DEEK | 0.2000–0.2500 | |
| Activating ubiquitin-mediated proteolysis | LAF | 0.3333 |
* Protein sequence is reviewed for UniProt database (). Peptide sequences obtained from Peptide Cutter . Potential bioactivities and occurrence frequency obtained from BIOPEP Amino acid nomenclature: A: Ala, R: Arg, N: Asn, D: Asp, C: Cys, Q: Gln, E: Glu, G: Gly, H: His, I: Ile, L: Leu, K: Lys, M: Met, F: Phe, P: Pro, S: Ser, T: Thr, W: Trp, Y: Tyr and V: Val.